MLH1 and cancer: As MMR gene-dependent differences in the immunogenicity of LS CRC have been reported before [51,52], we performed an MMR gene-wise comparison of immune infiltration, focusing on the MLH1-associated CRCs representing the vast majority in our incident cancer group (24/28).